Log in to your Inderes Free account to see all free content on this page.

I-tech

50.20 SEK

+5.46 %

Less than 1K followers

ITECH

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview

Financials & Estimates

Ownership

Dividend

Investor consensus

+5.46 %

+13.83 %

-3.83 %

-8.39 %

-47.27 %

-38.40 %

-31.04 %

-32.16 %

+103.53 %

I-tech operates in marine technology. The company conducts research and development of substances that inhibit marine fouling on ship hulls. In addition, the products can be used for various marine installations in fish farming and offshore. Customers are found in the marine paint industry and among other players in the shipping industry. I-Tech was founded in 2000 and has its headquarters in Mölndal.

Market cap

602.29M SEK

Turnover

1.6M SEK

Revenue

EBIT %

P/E

Dividend yield-%

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

7.5.

2026

Interim report Q1'26

21.8.

2026

Interim report Q2'26

16.10.

2026

Interim report Q3'26

All

Press releases

3rd party

ShowingAll content types

Press release2/9/2026, 9:46 AM

Redeye: I-Tech (Q4 Review): Short-term volatility persists, long-term case intact

Third party research2/6/2026, 6:20 AM

I-tech: A pause in pace, not the story - ABG

* Q4: -23% organic growth (vs. ABGSCe -12%) * Financially constrained customer weighed on ’25 org. growth * Long-term potential intact, expect continued CMP growth in '26e 2025, a mixed financial year Q4 organic growth came in below our estimate at -...

Press release2/5/2026, 10:20 AM

Correction: Time for live year-end report presentation

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Third party research2/5/2026, 10:06 AM

I-tech: Customer pullback weighing on growth - ABG

Sales -13% vs. ABGSCe, EBIT SEK 7.6m vs. ABGSCe 9.4m * Three coating products launched in Korea in Q4 * Sizeable customer with financial constraints impacting volumes Q4 results I-Tech reported sales of SEK 39m, falling 13% short of our estimate (-33...

Regulatory press release2/5/2026, 7:00 AM

I-Tech AB (publ) (ticker: ITECH) publish the year-end report for 2025

Third party research1/29/2026, 8:48 AM

I-tech: No easy lap into Q4e - ABG

* Q4e sales SEK 45m (58m), adj. EBIT SEK 10m (19m) * We cut '26e-'27e sales and EBIT by 10% and 22-19%, respectively * Lowered growth assumptions for CMP Tough comps in Q4e We estimate Q4 sales of SEK 45m, -23% y-o-y (-12% organic, -11% FX). I-Tech is...

Regulatory press release12/17/2025, 3:30 PM

Raouf Kattan resigns as a board member of I-Tech AB (publ)

Third party research11/27/2025, 9:39 AM

I-tech: Proposed non-renewal of Selektope in the EU - ABG

* European Commission drafts proposal for non-renewal of Selektope* Limited impact on near-term estimates, EU ~2% of total sales* Voting expected to occur some time in H1'26, final decision in mid-26European Commission drafts proposal for non-renewal...

Regulatory press release11/27/2025, 7:45 AM

I-Tech strongly rejects the European Commission’s proposed non-renewal of Medetomidine under the EU Biocidal Products Regulation (BPR)

Press release11/24/2025, 9:00 AM

I-Tech and Havey sign MoU to collaborate on the development of next-generation antifouling materials

Press release11/18/2025, 9:00 AM

I-Tech's Nomination Committee appointed

Press release10/21/2025, 8:25 AM

Redeye: I-Tech (Q3 Review) - Forecasts Trimmed, Long-Term View Unchanged

Third party research10/20/2025, 7:17 AM

I-tech: Customer slowdown tempers growth - ABG

* Q3 softer due to sizeable customer trimming '25 volumes* '25e-'27e sales cut by 11-6% and '26e-'27e EBIT by 12-8%* We believe I-Tech remains strongly positioned to grow market shareGrowth dampened by customer volume cutsI-Tech reported weaker than ...

Third party research10/17/2025, 7:05 AM

I-tech: Q3 impacted by weaker market conditions - ABG

Sales -18% vs. ABGSCe, EBIT SEK 11m vs. ABGSCe 16m* Newbuild market down 50% y-o-y, affecting growth* Sizeable customer has reduced planned volumes for '25Q3 resultsQ3 sales came in lower than expected at SEK 41m (-18% vs. ABGSCe 50m). The company writes...

Regulatory press release10/17/2025, 6:00 AM

I-Tech AB (publ) (ticker: ITECH) publish the interim report for the third quarter 2025

Third party research10/7/2025, 7:09 AM

I-tech: Sales recovery expected in Q3 - ABG

* Report out on 17 October* Q3e sales of SEK 50m, +23% y-o-y, EBIT SEK 16m (9m)* Q3 rebound expected after Q2 dip Q3 expectations We estimate Q3 sales of SEK 50m, +23% y-o-y (+35% organic, -12% FX). We expect Q3 to demonstrate that Q2 was a temporary...

Press release8/25/2025, 9:24 AM

Redeye: I-Tech - Q2 Review – Temporary Slowdown

Third party research8/25/2025, 5:28 AM

I-tech: A pause, not a stop - ABG

* Weaker Q2 due to natural quarterly variations* Cut '25e-'27e EBIT by 12-13%* Demand intact, rebound expected in Q3Growth halted, but we expect a rebound in Q3I-Tech reported weaker Q2 sales of SEK 32m (-39% vs. ABGSCe, -26% y-o-y) and EBIT of SEK 5m...

Third party research8/22/2025, 7:42 AM

I-tech: Big Q2 miss halts sales growth - ABG

* Sales -39% vs. ABGSCe, EBIT SEK 5m vs. ABGSCe 16m * Weak Q2 due to inventory build-up following strong Q4/Q1* Gross margin continues to improve (59% vs. ABGSCe 56%) Weaker Q2 than expected Sales came in lower than expected at SEK 32m (-39% vs. ABGSCe...

Regulatory press release8/22/2025, 6:00 AM

I-Tech AB (publ) (ticker: ITECH) publish the interim report for the second quarter 2025

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.